Leading Team in Medical Dermatology and Aesthetics
Diane Stroehmann, MS, RAC
Chief of Staff, Head of Regulatory Affairs and Quality
Diane Stroehmann, MS, RAC served as Vice President of Regulatory Affairs, Pharmacovigilance and Research Compliance at Kythera Biopharmaceuticals, Inc., from September, 2013 until it was acquired by Allergan in October, 2015, where she led the successful submission and approval of KYBELLA® in the US and Canada in addition to multiple international filings.
Prior to that, Ms. Stroehmann led the Regulatory Affairs group at Medicis Pharmaceutical Corporation with a focus on medical dermatology and aesthetic products. While at Medicis from March 2004 to August 2013, Ms. Stroehmann was involved in key product approvals in dermatology and aesthetic medicine including SOLODYN®, VANOS®, LUZU®, DYSPORT®, and RESTYLANE®.
Ms. Stroehmann received a BS in Biology from the University of Illinois Champaign-Urbana, and a MS in Regulatory Affairs from San Diego State University.